Finally, the meta-analysis by Chen XL and colleagues in 2017 showed that TGF-β tissue expression can be used as a prognostic biomarker for CRC patients undergoing surgery, especially for CRC patients from Western countries [35]. Here, TGFB1 is linked to colorectal carcinoma.